Skip to main content
Acta Pharmaceutica Sinica. B logoLink to Acta Pharmaceutica Sinica. B
. 2022 Sep 27;12(12):4525. doi: 10.1016/j.apsb.2022.09.013

Author correction to ‘Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases’ [Acta pharmaceutica sinica B 12 (2022) 1740–1760]

Minyang Fu 1, Dandan Peng 1, Tianxia Lan 1, Yuquan Wei 1, Xiawei Wei 1,
PMCID: PMC9764062  PMID: 36562005

The authors regret that there was an error in 7. Conclusion and prospect section of the article. The last paragraph of this section ‘Under particular external … integrins interact with CT domain’ is supposed to be the content of the figure legend (Fig. 1). It is superfluous in this part and should be deleted. The revision does not affect any conclusions of this work.

The authors apologize for any inconvenience caused to the journal and readers.

Footnotes

Peer review under responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.


Articles from Acta Pharmaceutica Sinica. B are provided here courtesy of Elsevier

RESOURCES